Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009

This publication has 21 references indexed in Scilit:

• Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
  Clinical Infectious Diseases, 2009
• Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
  Clinical Infectious Diseases, 2008
• Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
  Clinical Infectious Diseases, 2008
• Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
  Clinical Infectious Diseases, 2008
• Fusarium Infections in Immunocompromised Patients
  Clinical Microbiology Reviews, 2007
• Treatment of Non-Aspergillus Moulds in Immunocompromised Patients, with Amphotericin B Lipid Complex
  Clinical Infectious Diseases, 2005
• Zygomycosis in a Tertiary‐Care Cancer Center in the Era ofAspergillus‐Active Antifungal Therapy: A Case‐Control Observational Study of 27 Recent Cases
  The Journal of Infectious Diseases, 2005
• Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
  Cancer, 2003
• Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
  Clinical Infectious Diseases, 2003
• Epidemiology, Molecular Mycology, and Environmental Sources ofFusariumInfection in Patients with Cancer
  Infection Control & Hospital Epidemiology, 2002